IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Biocon and Mylan to Collaborate in Generic Biologics

8:00 AM MDT | July 10, 2009 | Deepti Ramesh

Mylan (Canonsburg, PA) says it has signed an agreement with biotechnology firm Biocon (Bangalore, India) for an exclusive collaboration for the development, manufacturing, and commercialization of multiple, high-value generic biologic compounds for the global market. Mazumdar-Shaw: To lower healthcare costs. The generic pharmaceutical industry, which is based almost entirely on chemically synthesized drugs, is poised for change, Biocon says. Governments worldwide are trying to facilitate the entry of generic biotech or protein derived drugs, in an effort to lower...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa